Artvin Coruh University has announced a new clinical trial aimed at investigating factors that contribute to urinary incontinence (UI) in patients with multiple sclerosis (MS). The study will also use electromyography (EMG) to assess pelvic floor muscle (PFM) activity, providing further insights into this key area of research. Although recruitment has not yet started, this study presents essential implications for the medical device and clinical research communities.
Publication Date: November 19, 2025
In this article:
- What changed?
- What does the study focus on?
- What are the implications for medical devices?
- FAQ
- Conclusion
- Disclaimer
- Announcement link
What changed?
The study announced by Artvin Coruh University will explore the relationships between multiple sclerosis and urinary incontinence, specifically targeting how pelvic floor muscle behavior may contribute to symptoms. Using advanced EMG assessments, researchers aim to provide clarity on this under-researched connection. Recruitment for the study has not yet begun, but clinical, quality, and regulatory teams should monitor its progress closely.
What does the study focus on?
Multiple sclerosis is a neurological condition with widespread effects on physical functions, including bladder control. This cross-sectional study will specifically identify factors linked to UI and use electromyography to measure pelvic floor muscle activity. Such measurements could help professionals better understand neuromuscular performance in MS patients, creating opportunities to refine treatment strategies and associated devices.
Study Design
Though details regarding participant numbers or methodology remain undisclosed, the study’s design will likely emphasize qualitative observations combined with quantitative EMG readings. These readings could provide high-resolution insights into how pelvic floor intervention impacts UI severity.
Who is leading this research?
This trial is sponsored by Artvin Coruh University, a research institution with ongoing contributions to fields such as rehabilitation and neurology. Universities like Artvin Coruh represent vital intersections between academia and clinical innovation, ensuring rigorous study protocols and potentially actionable results.
What are the implications for medical devices?
The use of EMG technology in this research highlights the growing importance of diagnostic and monitoring devices in personalized medicine. Clinical device manufacturers focusing on pelvic floor stimulation or monitoring should follow this study closely to evaluate opportunities for product refinement or new development.
Furthermore, regulatory professionals may see a need for updated guidance surrounding these devices, particularly in designing tools optimized for MS-related UI needs. As this research progresses, it could also influence reimbursement policies and local regulatory pathways.
FAQ
- 1. When will recruitment begin?
Recruitment has not yet started, but updates may follow soon. - 2. What devices will be used in the study?
The study mentions the use of electromyography (EMG) but does not specify additional devices. - 3. Is this study open to all MS patients?
Eligibility criteria have not been published. Researchers will likely outline inclusion and exclusion parameters closer to recruitment dates. - 4. How can clinical teams stay informed?
Clinical professionals can monitor updates on ClinicalTrials.gov or subscribe to announcements from Artvin Coruh University.
Conclusion
The upcoming study by Artvin Coruh University presents exciting opportunities for advancing research surrounding urinary incontinence in MS patients. With a focus on pelvic floor muscle activity and the use of EMG technology, this initiative could drive innovation across clinical and device-related fields. Medical stakeholders are encouraged to monitor project developments actively.
Disclaimer
This article provides general information about developments in medical research and devices. It does not constitute legal advice or clinical guidance. Professionals should consult appropriate regulatory or clinical resources for specific decisions.
Announcement link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07236684?term=medical+device